F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review, the facility failed to ensure there was an adequate indication for the
use of permethrin cream (a medication used to treat scabies [a condition caused by tiny insects called
mites] that infest and irritate a person's skin) and ivermectin (a medication that treats infections caused by
roundworms, threadworms, and other parasites [organism that lives on or in a host organism and gets its
food from or at the expense of its host]) for one of three sampled residents (Resident 1).
Residents Affected - Few
This deficient practice had the potential to result in the use of unnecessary medication and cause adverse
side effects (an undesired harmful effect resulting from a medication or other intervention) such as burning,
itching, numbness, rash, redness, stinging, swelling of the skin, weakness, uncontrollable shaking of a part
of the body, and chest discomfort.
Findings:
A review of Resident 1's admission Record indicated the facility readmitted Resident 1 on 3/22/2023 with
diagnoses that included chronic obstructive pulmonary disease (refers to a group of diseases that cause
airflow blockage and breathing-related problems), personal history of other diseases of the digestive
system, and schizoaffective disorder (is a mental health condition with symptoms of both schizophrenia [a
disorder that affects a person's ability to think, feel, and behave clearly] and mood disorders [described by
marked disruptions in emotions]).
A review of Resident 1's Minimum Data Set (MDS- a standardized assessment and screening tool) dated
6/9/2023 indicated Resident 1's cognitive (knowledge and understanding through thought, experience, and
senses) skills for daily decision making was intact. The MDS also indicated Resident 1 was independent
with bed mobility, transfer, locomotion on and off unit, dressing, eating, toilet use, and personal hygiene.
A review of Resident 1's Dermatology (branch of medicine dealing with the skin) Note dated 5/23/2023,
indicated a diagnosis of dermatitis (a common condition that causes swelling and irritation of the skin)
unspecified.
A review of Resident 1's physician's orders dated 5/23/2023, indicated an order for permethrin cream 5%,
apply to neck to toes topically one time a day for dermatitis unspecified for four weeks. Apply from neck to
toes at 9 p.m. Leave on for 12 hours then shower at 9 a.m.
A review of Resident 1's physician's orders dated 5/23/2023, indicated an order for ivermectin oral tablet,
give 15 milligrams (mg- unit of measurement) by mouth one time a day every Wednesday for dermatitis
unspecified for four weeks.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
555519
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555519
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/10/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Care Center on Hazeltine, LLC
6835 Hazeltine Ave.
Van Nuys, CA 91405
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
A review of Resident 1's Lab Results Report, reported date 6/8/2023, indicated scabies exam result: no
sarcoptes scabei (itch mite that causes scabies) seen.
During a concurrent interview and record review on 12/14/2023 at 11:00 a.m., with the Infection
Preventionist (IP), reviewed Resident 1's Treatment Administration Record (TAR) for 6/2023, Medication
Administration Record (MAR) for 5/2023 and 6/2023, and progress notes and dermatology notes for
5/2023. The IP stated that there was no documented evidence that Resident 1 had a diagnosis of scabies.
The IP stated the facility administered permethrin cream to Resident 1 on 6/2/23 and administered
ivermectin 15 mg on 5/24/2023, 5/31/2023, and 6/7/2023. The IP stated that both medications were ordered
by the dermatologist (physician who specializes in treating the skin, hair, and nails) which is why the
medications were administered. The IP stated Resident 1 was diagnosed with dermatitis and stated
permethrin is a medication used for scabies.
During an interview on 12/14/2023 at 11:22 a.m., with the Director of Nursing (DON), the DON stated that
Resident 1 had a rash, which is why the dermatologist prescribed the permethrin cream and the ivermectin.
The DON stated that Resident 1 did not have a diagnosis of scabies.
A review of the facility's policy and procedure titled, Unnecessary Drugs, revised 3/2023, indicated each
resident shall be free of unnecessary drugs. Under guidelines: Unnecessary drugs include but not limited to
medications used: b. For excessive duration; d. without adequate indications; f. any combinations of the
aforementioned reasons.
A review of an article in MedlinePlus titled, Permethrin Cream, copyrighted 2023, indicated permethrin is
used to treat scabies (mites that attach themselves to the skin) in adults and children 2 months of age and
older.
A review of an article in MedlinePlus titled Ivermectin, copyrighted 2023, indicated ivermectin is used to
treat strongyloidiasis (threadworm; infection with a type of roundworm that enters the body through the skin,
moves through the airways and lives in the intestines). Ivermectin is also used to control onchocerciasis
(river blindness; infection with a type of roundworm that may cause rash, bumps under the skin, and vision
problems including vision loss or blindness).
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555519
If continuation sheet
Page 2 of 2